Literature DB >> 20046084

[Comparison of diagnostic utility between procalcitonin and C-reactive protein for the patients with blood culture-positive sepsis].

Mina Hur1, Hee-Won Moon, Yeo-Min Yun, Kyung Hee Kim, Hyun Soo Kim, Kyu Man Lee.   

Abstract

BACKGROUND: Procalcitonin (PCT) is a relatively new marker for bacterial infections, and its diagnostic utility has been variable across the studies. We investigated the diagnostic utility of PCT for the patients with blood culture-positive sepsis, and compared it with that of C-reactive protein (CRP).
METHODS: In 1,270 consecutive blood samples, PCT and CRP were simultaneously measured and results were compared according to the five categories of PCT concentrations (<0.05 ng/mL; 0.05-0.49 ng/mL; 0.5-1.99 ng/mL; 2-9.99 ng/mL; > or = 10 ng/mL). In 506 samples, they were further analyzed according to the result of blood culture. PCT and CRP were measured using enzyme-linked fluorescent assay (bioMerieux Co., France) and rate nephelometry (Beckman Coulter Co., USA), respectively. Their diagnostic utilities were compared using ROC curves.
RESULTS: The mean concentrations of CRP in five categories of PCT were 15.4 mg/L, 42.1 mg/L, 101.2 mg/L, 125.0 mg/L, 167.1 mg/L, respectively (P<0.0001). Both PCT and CRP showed significant differences between the two positive and negative groups of blood culture (PCT, 8.47 vs 2.44 ng/mL, P=0.0133; CRP, 110.48 vs 59.78 mg/L, P<0.0001). The areas under the ROC curves (95% confidence interval) for PCT and CRP were 0.720 (0.644-0.788) and 0.558 (0.478-0.636), respectively, and showed a significant difference (P=0.005).
CONCLUSIONS: The diagnostic utility of PCT is superior to that of CRP for the patients with blood culture-positive sepsis. PCT seems to be reliable for sepsis diagnosis, and may provide useful information for the critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20046084     DOI: 10.3343/kjlm.2009.29.6.529

Source DB:  PubMed          Journal:  Korean J Lab Med        ISSN: 1598-6535


  14 in total

Review 1.  Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective.

Authors:  Claudio Ronco; Matthieu Legrand; Stuart L Goldstein; Mina Hur; Nam Tran; Eric C Howell; Vincenzo Cantaluppi; Dinna N Cruz; Kevin Damman; Sean M Bagshaw; Salvatore Di Somma; Andrew Lewington
Journal:  Blood Purif       Date:  2014-07-03       Impact factor: 2.614

2.  Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever.

Authors:  Myeong Hee Kim; Gayoung Lim; So Young Kang; Woo-In Lee; Jin-Tae Suh; Hee Joo Lee
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

3.  Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases.

Authors:  Kowoon Joo; Won Park; Mie-Jin Lim; Seong-Ryul Kwon; Jiyeol Yoon
Journal:  J Korean Med Sci       Date:  2011-09-01       Impact factor: 2.153

4.  Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients.

Authors:  Wan Soo Lee; Dae Woong Kang; Jong Hun Back; Hyun Lee Kim; Jong Hoon Chung; Byung Chul Shin
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

5.  Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient.

Authors:  Waheeda Nargis; Md Ibrahim; Borhan Uddin Ahamed
Journal:  Int J Crit Illn Inj Sci       Date:  2014-07

6.  Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis.

Authors:  Mina Hur; Hanah Kim; Seungho Lee; Flavia Cristofano; Laura Magrini; Rossella Marino; Chiara Serena Gori; Cristina Bongiovanni; Benedetta Zancla; Patrizia Cardelli; Salvatore Di Somma
Journal:  BMC Infect Dis       Date:  2014-04-24       Impact factor: 3.090

7.  Diagnostic value of procalcitonin and CRP in critically ill patients admitted with suspected sepsis.

Authors:  Jae-Sik Joen; Sung-Mi Ji
Journal:  J Dent Anesth Pain Med       Date:  2015-09-30

8.  Clinical values of the early detection of serum procalcitonin, C-reactive protein and white blood cells for neonates with infectious diseases.

Authors:  Shiwen Liu; Yunxiu Hou; Haili Cui
Journal:  Pak J Med Sci       Date:  2016 Nov-Dec       Impact factor: 1.088

9.  Comparison of efficiency of inhaled and intravenous corticosteroid on pregnant women with COPD and the effects on the expression of PCT and hs-CRP.

Authors:  Yuliang Zhao; Fei Li; Yangwen Liu; Yingjun Shi; Zhihai Li; Guangke Cao; Wang Zhu
Journal:  Exp Ther Med       Date:  2018-03-30       Impact factor: 2.447

10.  Usefulness of serum procalcitonin as a diagnostic biomarker of infection in children with chronic kidney disease.

Authors:  Fatina I Fadel; Manal F Elshamaa; Eman A Elghoroury; Ahmed M Badr; Solaf Kamel; Marwa M El-Sonbaty; Mona Raafat; Hebatallh Farouk
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.